BioSpace News Archive

Bayer will present new data from across its oncology portfolio at the upcoming European Society for Medical Oncology (ESMO) Congress taking place in Madrid, Spain from October 20-24, 2023. The breadth of new data showcases Bayer’s ongoing commitment to supporting patients living with cancer.

Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that it has achieved another milestone in its development of an implantable continuous glucose monitor (CGM) by commencing preclinical animal testing.

DermTech, Inc. will host a conference call and webcast on Thursday, November 2, 2023 at 5:00 p.m. Eastern Time (ET) to discuss the Company’s third-quarter 2023 operating and financial results.

Cardio Diagnostics Holdings, Inc, a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, announced the launch of the Company’s new integrated facility in Iowa City, Iowa.

ValGenesis, Inc. and Brevitas, an independent technology consulting firm, have partnered to introduce the ValGenesis product suite alongside Brevitas’ immense technical expertise in life sciences across the US and Canada.

Today, World Arthritis Day, the Arthritis Foundation announced the launch of the first-ever clinical trial directed and sponsored by the Foundation. It will focus on patients at high risk for post-traumatic osteoarthritis (PTOA) in the knee.

SentiAR, Inc. a St. Louis, Missouri based pioneer in using Augmented Reality (AR) visualization technology for medical procedures has received their second FDA 510K clearance CommandEP™ adding a new integration.

Veracyte, Inc. (Nasdaq: VCYT) today announced that new data presented at the American College of Chest Physicians (CHEST) Annual Meeting 2023 demonstrate the clinical utility of the company’s Envisia Genomic Classifier, which is used by physicians to improve diagnostic and prognostic confidence of interstitial lung diseases (ILDs).

Zynex, Inc. (NASDAQ: ZYXI) will hold a conference call on Thursday, October 26, 2023 at 4:15 PM Eastern Time to discuss its financial results for the third quarter ended September 30, 2023.

GE HealthCare announced it signed a $44 million contract with the Biomedical Advanced Research and Development Authority —part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services —to develop and obtain regulatory clearance for next-generation advanced point-of-care ultrasound technology with new artificial intelligence applications.